iShares Core Growth Allocation ETF vs ARK Genomic Revolution ETF — how do they compare? iShares Core Growth Allocation ETF trades at $69.87, while ARK Genomic Revolution ETF trades at $44.49. Which is the better fit depends on your goals.
| AOR | ARKG | |
|---|---|---|
52-Week High | $70.12 | $44.55 |
52-Week Low | $62.26 | $24.02 |
Sector | — | Sector/Thematic |
Trailing returns across standard periods
The fund is a fund of funds and seeks its investment objective by investing primarily in underlying funds that themselves seek investment results corresponding to their own respective underlying indexes. It generally will invest at least 80% of its assets in the component securities of its underlying index. The index measures the performance of the S&P Dow Jones Indices LLC proprietary allocation model.
Read more on AOR →ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →